Please provide your email address to receive an email when new articles are posted on . Up to 88% of sentinel lymph node biopsies (SNLB) return with a negative result. The DecisionDx-Melanoma test, ...

Patients identified as low risk by DecisionDx-Melanoma had a 2.8% sentinel lymph node (SLN) positivity rate, well below the National Comprehensive Cancer Network® (NCCN) guidelines’ 5% threshold to ...

ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for cancer in their lymph nodes — a finding that could ...

TAMPA, Fla. (Oct. 22, 2025) — A large multicenter clinical trial published in JAMA Surgery shows that a gene expression profile–based test can reliably identify melanoma patients who have a low risk ...

37% of patients were classified as low risk by the test. The rate of sentinel node positivity among low-risk patients was 7.1%, compared with 23.8% in the high-risk group.

Exact Sciences, a leading provider of cancer screening and diagnostic tests, today announced that the UK’s National Institute for Health and Care Excellence (NICE) has recommended the expanded use of ...

Stanford University-led researchers report that tumor cells hijack mitochondria from immune cells, reducing anti-tumor immune ...

Lymphoma in the legs can cause swelling and skin rashes in addition to fever, unintentional weight loss, and fatigue. Treatment may include chemotherapy, radiation, and stem cell transplants. Your ...

ESPN college basketball analyst Dick Vitale announced Friday that a biopsy revealed a cancerous lymph node in his neck, which will lead to surgery on Tuesday. The 85-year-old Vitale has been calling ...